Akari Therapeutics Plc (AKTX)

0.2677 +0.01 (+4.98%) USD  |  NASDAQ  |  Feb 25, 16:00
0.2677 0.00 (0.00%) After-Hours: 16:42
More

Akari Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --
NuCana Plc --
Autolus Therapeutics Plc Upgrade